观察CD 2ap在囊性肾透明细胞癌中的表达及其与临床病理特征的关系。
Observed the expression of CD2AP in multilocular cystic renal cell carcinoma and its relationship with clinic pathologic feature.
目的探讨CD 2相关蛋白(CD2AP)在囊性肾透明细胞癌中的表达及其与临床病理特征的关系。
Objective To explore expression of CD2-associated protein (CD2AP) in multilocular cystic renal cell carcinoma and its relationship with clinic pathologic feature.
肾透明细胞癌高表达免疫抑制分子的机制需进一步研究。
The mechanisms of high expression of immunosuppressive molecules in the advanced stage ccRCCs require further investigation.
本实验将通过研究女性肾透明细胞癌及正常肾组织的X染色体失活类型判断肾透明细胞癌克隆起源。
To assess the clonal origin of renal clear cell carcinomas by the study of X-chromosome inactivation pattern in female clear cell renal carcinomas and normal renal tissues.
目的研究肾透明细胞癌中趋化性细胞因子受体CX CR4的分布。
To explore distribution of chemokine receptor CXCR4 on clear cell renal carcinoma.
结论：国人非遗传性肾透明细胞癌中存在VHL基因的突变，且与患者年龄，肿瘤分期、分级无相关性。
The mutations of VHL gene were irrespective of the age and pathological grade and stage of patients.
多房性肾细胞癌的囊内有透明细胞的聚集，其间有分隔。
Multilocular renal cell carcinoma has aggregates of clear cells within the septa dividing cystic Spaces.
方法回顾性分析5例肾透明细胞癌转移瘤行手术治疗患者的临床资料。
Methods The clinical data of 5 patients with kidney carcinoma after metastasectomy were retrospectively analyzed.
结论国人原发性散发性肾透明细胞癌中存在VHL基因的突变。
Conclusion The VHL gene may frequently mutate in Chinese patients with primary sporadic renal clear cell carcinoma.
目的研究环氧化酶-2（COX-2）在人肾透明细胞癌组织中的表达，分析其表达水平与肿瘤分期的关系。
Objective To study the expression of cyclooxygenase-2 (COX-2) in renal clear cell carcinoma tissues and its relation with the clinical tumor stage.
螺旋CT鉴别透明细胞癌与非透明细胞癌的准确性在皮髓质期、肾实质期、排泄期分别为93.5%、86.9%、81.5%。
Accuracy of ct for differentiating clear cell and non-clear cell carcinoma in three enhanced phases was 93.5%, 86.9% and 81.5%, respectively.
螺旋CT鉴别透明细胞癌与非透明细胞癌的准确性在皮髓质期、肾实质期、排泄期分别为93.5%、86.9%、81.5%。
Accuracy of ct for differentiating clear cell and non-clear cell carcinoma in three enhanced phases was 93.5%, 86.9% and 81.5%, respectively.
应用推荐